Skip to main content

Security report for cslbehring.cl

CSL Behring Chile · Healthcare · Chile

Medium risk. 4 critical or high findings in Email security, Security headers and 1 other check.

Security score

70/100

Risk levelMedium

0–100, higher is better. How it is calculated

CSL Behring Chile is a specialized pharmaceutical company focused on developing and providing innovative treatments for rare and serious diseases. The website targets healthcare professionals and patients in Chile, offering detailed information about their products, patient support, and educational resources. The company is a subsidiary of CSL Limited, a global biotechnology leader. The site demonstrates a professional digital presence with consistent branding and comprehensive content in Spanish. Technically, the website employs modern technologies such as Google Tag Manager and OneTrust for analytics and cookie consent, and it is well optimized for mobile and accessibility. Security posture is solid with HTTPS and cookie consent mechanisms, though it lacks publicly available security policies and incident response contacts. WHOIS data is unavailable due to domain query failure, which slightly impacts trust but the overall legitimacy is supported by the professional site and parent company linkage. Recommendations include publishing security policies and incident response information, and providing direct company contact details to enhance trust and compliance.

Scanned

NIS2 and GDPR posture

GDPR outside view
88/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

4 findings rated critical or high. Fix these first.

  1. Email security

    SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.

    • Critical

      No email authentication configured

      Domain is vulnerable to email spoofing

      What to do: Implement SPF, DKIM, and DMARC immediately

    • High

      No SPF record found

      SPF helps prevent email spoofing

      What to do: Add SPF record: "v=spf1 include:_spf.yourmailprovider.com ~all"

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  3. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

Need hands-on remediation? Email guard@offseq.com

Keep watching cslbehring.cl

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
67
Security headers
50
Email security
40
DNS health
75
Network security
100
GDPR outside view
88
Average
70

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company operates in the healthcare sector, focusing on rare diseases and specialty medicines. Its market position is strong as a leader in this niche, supported by a broad portfolio of recombinant and plasma-derived products. The business model revolves around pharmaceutical innovation, patient support, and professional education. The website reflects a mature digital strategy with multilingual support and global presence links. Partnerships and parent company relationships are clearly indicated, enhancing credibility. Growth indicators include active content updates and online learning platforms. The company maintains a consistent brand image and leverages social media channels for outreach. However, the absence of direct contact information and WHOIS data limits full transparency.

Security posture

The website enforces HTTPS with a good SSL configuration and uses cookie consent tools compliant with GDPR. Security headers are not explicitly detected in the provided data, and no security.txt or vulnerability disclosure pages are found. There is no published security policy or incident response contact, which are gaps in the security maturity. No vulnerabilities or exposed sensitive data were identified in the analysis. The use of trusted third-party services like Google Tag Manager and OneTrust indicates a moderate level of security awareness. Overall, the security posture is adequate but could be improved by publishing formal security documentation and incident response procedures.

Recommendations

  1. Publish a comprehensive security policy and incident response plan on the website.
  2. Provide direct company contact emails and phone numbers for support and security reporting.
  3. Implement and publish a vulnerability disclosure or security.txt file to encourage responsible reporting.
  4. Enhance security headers and perform regular security audits to identify and mitigate vulnerabilities.
  5. Improve WHOIS domain registration transparency or ensure domain registration data is publicly accessible.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
CSL Behring Chile
Description
CSL Behring Chile is focused on innovative treatments for rare and serious diseases, offering a portfolio of recombinant and plasma-derived products for bleeding disorders, immune deficiencies, chronic inflammatory demyelinating polyneuropathy, hereditary angioedema, and alpha-1 antitrypsin deficiency.
Key services
Innovative medicines, Patient support, Online learning for healthcare professionals
Content quality
good
Branding
consistent

Technology

Stack
Google Tag Manager, OneTrust Cookie Consent, Plyr video player
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism

Analytics and tracking

Services
Google Tag Manager
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
OneTrust Cookie Consent
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content in Spanish targeting Chilean audience.
  2. No WHOIS data available due to invalid domain query; domain registration details unknown.
  3. Strong privacy and cookie policies with consent mechanisms implemented.
  4. No direct company contact emails or phone numbers found; contact via web form only.
  5. No explicit security policy or incident response information published.
  6. Use of modern tracking and consent technologies like Google Tag Manager and OneTrust.
  7. No signs of adult or unsafe content; content is healthcare and pharmaceutical focused.
  8. Social media presence on LinkedIn, Twitter, YouTube, Instagram, Facebook confirmed.
  9. Website uses HTTPS with good SSL configuration.
  10. No WAF or blocking detected; site content is not blocked or challenged.
Technical notes

Notes

The website uses a modern tech stack including Google Tag Manager for analytics and OneTrust for cookie consent management, indicating compliance with privacy regulations. The Plyr video player is used for multimedia content. The site is mobile optimized with good accessibility features and SEO meta tags. Performance is moderate, with no critical errors or broken elements detected. The CMS or hosting provider is not explicitly identified. The site structure is clear with well-organized navigation and consistent branding. Opportunities exist to enhance technical documentation and security headers to further improve the technical maturity and resilience.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with cslbehring.cl. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review cslbehring.cl.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.